Inogen Inc (INGN) financials

NASDAQ · Health Care

$6.86 -5.51% Close Oct 30, 2026 Live

Inogen revenue and earnings by year

Inogen's revenue was $349 million in the fiscal year to December 31, 2025, up 3.9% from the year before. Net income was -$22.7 million, -6.5% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 6.2% a year on average.

RevenueNet income
$0$200M
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue349336316377358308362358249203
Revenue growth3.9%6.4%-16.3%5.4%16.1%-14.8%1.1%43.6%23.0%—
Gross profit15415512715417613817217912197
Gross margin44.2%46.1%40.1%40.7%49.3%44.8%47.5%49.9%48.6%48.0%
Operating income-30-43-109-859-1220382823
Operating margin-8.7%-12.7%-34.7%-22.6%2.6%-3.9%5.5%10.6%11.1%11.3%
Net income-23-36-102-84-6-621522121
Net margin-6.5%-10.7%-32.5%-22.2%-1.8%-1.9%5.8%14.5%8.4%10.1%
Diluted EPS-$0.86-$1.52-$4.42-$3.67-$0.28-$0.26$0.94$2.30$0.95$0.98
Free cash flow-22-11-30-59-01934475023

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open INGN in Markets.

See also: INGN valuation and P/E history · INGN returns

No forecast, no recommendation. This page describes Inogen Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.